
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon is a leader in the vision care industry, with a strong portfolio of contact lenses, lenscare solutions, and ocular health products. Their recent spin-off from Novartis and strong product cycle are expected to fuel sustainable revenue growth and margin improvement. Despite softer market conditions, Alcon's P&L execution and new product launches allow for a positive outlook on the company's future performance.
Bears say
Alcon is facing a number of challenges in the near term, including a slowdown in the global cataract market and increased potential competition in the surgical segment. Additionally, the company has been experiencing supply chain issues and recalls, which could impact revenue growth and margins. These factors, combined with a high valuation and the potential for increased pricing pressure, lead to a negative outlook on the stock.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares